EX-99.1 2 talk-ex99_1.htm EX-99.1 EX-99.1

 

Exhibit 99.1

img227085625_0.jpg 

Talkspace Reports 2021 Full Year and Fourth Quarter Results

Revenue grew 49% in 2021 to $114 million, driven by continued strong B2B performance

Completed B2B sessions grew 139% in 2021 versus the prior year

B2B eligible lives increased 75% in 2021 compared to the prior year


NEW YORK, February 22, 2022 –
Talkspace, Inc. (Nasdaq: TALK), a leading virtual behavioral healthcare company, today reported 2021 full year and fourth quarter results as summarized below. All financial results refer to 2021 full year or fourth quarter and the applicable prior-year period unless otherwise stated.

 

 

 

Three Months

 

 

Twelve Months

 

Periods ended December 31, 2021

 

Results

 

Variance from Prior Year

 

 

Results

 

Variance from Prior Year

 

(In thousands unless otherwise noted, unaudited)

 

 

 

 

 

 

 

 

 

 

Number of B2B eligible lives (in millions)

 

 

69

 

 

75

%

 

 

69

 

 

75

%

Number of active members 1

 

 

55.6

 

 

11

%

 

 

55.6

 

 

11

%

Number of completed B2B sessions

 

 

81.6

 

 

52

%

 

 

273.7

 

 

139

%

 

 

 

 

 

 

 

 

 

 

 

Total revenue

 

$

29,172

 

 

14

%

 

$

113,671

 

 

49

%

Gross profit

 

$

15,971

 

 

(5

%)

 

$

66,772

 

 

34

%

Gross margin %

 

 

55

%

~(1,000) bps

 

 

 

59

%

~(700) bps

 

Operating expenses

 

$

44,549

 

 

61

%

 

$

160,695

 

 

124

%

Net income (loss)

 

$

(21,068

)

*

 

 

$

(62,742

)

*

 

Adjusted EBITDA 2

 

$

(17,565

)

*

 

 

$

(60,868

)

*

 

Cash and cash equivalents

 

$

198,256

 

*

 

 

$

198,256

 

*

 

* = not meaningful

(1) Reflects active members at the end of the period.

(2) Adjusted EBITDA is a non-GAAP financial measure. For a reconciliation to the most directly comparable GAAP measure, see “Reconciliation of Non-GAAP Results to GAAP Results.”

 

“We delivered revenue and gross profit growth in 2021, led by increasing demand for our B2B services, partially offset by a decline in our consumer business in the final months of the year,” said Chief Financial Officer Jennifer Fulk. “Importantly, we made progress on our near-term priorities as we continue to invest in growth initiatives and optimize our business mix, setting the stage for long term value creation.”
 

Full Year 2021 Key Performance Metrics

 

Revenue grew 49% to $114 million, driven primarily by business-to-business (“B2B”) growth in covered lives from health plan clients and new enterprise clients, along with increased business-to-consumer (“B2C”) member subscriptions, partially offset by an increase in revenue reserves on receivables of $4.1 million from existing health plan clients.
Gross profit grew 34% to $67 million. Gross margin declined to 59% due to a revenue mix shift toward B2B, a greater number of full-time therapists added to Talkspace’s network, and the revenue reserves referenced above.
Net loss was ($63) million, compared to a net loss of ($22) million in the prior year, driven primarily by higher customer acquisition costs and an increase in headcount, as well as stock-based compensation expense. This was partially offset by non-cash gains related to revaluation of warrant liabilities. Adjusted EBITDA loss was ($61) million, compared to ($18) million in the prior year.

 

 

 


 

 

Fourth Quarter 2021 Key Performance Metrics

 

Revenue grew 14% to $29 million, driven by an increase in covered lives from health plan clients and new enterprise clients, a higher number of completed B2B sessions, and a favorable revenue reserve on receivables from prior periods of $0.8 million. This was offset by B2C revenue decline of 15% due in part to reduced marketing spend. The $0.8 million revenue reserve favorably impacted revenue growth by 3 percentage points.
Gross profit declined 5% to $16 million, and gross margin declined to 55%, due to a revenue mix shift toward B2B and a greater number of full-time therapists added to Talkspace’s network, partially offset by the favorable revenue reserve allowance referenced above. The $0.8 million revenue reserve favorably impacted gross margin by 1.2 percentage points.
Net loss was ($21) million, compared to a net loss of ($11) million in the prior-year period, driven primarily by higher customer acquisition costs, employee-related expenses including one-time cash severance costs, and stock-based compensation. Adjusted EBITDA loss was ($18) million, compared to ($9) million in the prior-year period.

 

 

 

Conference Call, Presentation Slides, and Webcast Details

 

Visit investors.talkspace.com to view a presentation related to 2021 full year and fourth quarter results and business outlook and listen to a conference call scheduled to begin at 5:00 p.m. ET on Tuesday, February 22, 2022. The conference call can also be accessed by dialing (888) 660-0107 for U.S. participants or (409) 216-0599 for international participants (participant code 3365024). A replay will be available shortly after the call’s completion and remain available for approximately 90 days.

 

About Talkspace

 

Talkspace is a leading virtual behavioral healthcare company enabled by a purpose-built technology platform. As a digital healthcare company, all care is delivered through an easy-to-use and fully encrypted web and mobile platform, consistent with HIPAA and other state regulatory requirements.

 

Today, the need for care feels more urgent than ever. When seeking treatment, whether it’s psychiatry or adolescent, individual or couples therapy, Talkspace offers treatment options for almost every need. With Talkspace, members can send their dedicated therapists text, video, and voice messages anytime, from anywhere, and engage in live video sessions. As of December 2021, over 2 million people have used Talkspace, and 69 million lives were covered for Talkspace through insurance and employee assistance programs or other network behavioral health paid benefit programs.

 

For more information about Talkspace commercial relationships, visit https://business.talkspace.com/. To learn more about online therapy, please visit https://www.talkspace.com/online-therapy/. To learn more about Talkspace Psychiatry, please visit https://www.talkspace.com/psychiatry.


 

 

 


 

 

 

Forward Looking Statements

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking, including statements regarding our financial condition, anticipated financial performance, achieving profitability, business strategy and plans, market opportunity and expansion and objectives of our management for future operations. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast”, “future”, “intend,” “may,” “might”, “opportunity”, “plan,” “possible”, “potential,” “predict,” “project,” “should,” “strategy”, “strive”, “target,” “will,” or “would”, the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many important factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: our history of losses; the rapid evolution of our business and the markets in which we operate; our ability to continue growing at the rates we have historically grown, or at all; the development of the virtual behavioral health market; COVID-19 and its impact on business and economic conditions; competition in our industry; and our relationships with affiliated professional entities to provide physician and other professional services. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described under the caption “Risk Factors” in our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021 filed with the Securities and Exchange Commission (“SEC”), and our other documents filed from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. We do not give any assurance that we will achieve our expectations.

 

Financial Disclosures

The financial results reported in this press release are unaudited and subject to change as additional information becomes available pending completion of the audit.

 

Contacts

‍For Investors:

Mike Lovell, Senior Director Investor Relations

515-771-1585

Mike.Lovell@Talkspace.com

 

Westwicke, an ICR Company

Bob East / Asher Dewhurst / Jordan Kohnstam

443-213-0500

TalkspaceIR@westwicke.com


 

 

 

 


 

Talkspace, Inc.

Consolidated Statements of Operations

(Unaudited)

 

 

 

Three months ended
December 31,

 

 

Variance

 

 

Twelve months ended
December 31,

 

 

Variance

 

 

 

2021

 

 

2020

 

 

$

 

 

%

 

 

2021

 

 

2020

 

 

$

 

 

%

 

(in thousands, except percentages and per share data)

 

 

 

 

Consumer revenue

 

$

16,471

 

 

$

19,378

 

 

$

(2,907

)

 

 

(15.0

)

 

$

74,757

 

 

$

61,586

 

 

$

13,171

 

 

 

21.4

 

Commercial revenue

 

 

12,701

 

 

 

6,310

 

 

 

6,391

 

 

 

101.3

 

 

 

38,914

 

 

 

14,604

 

 

 

24,310

 

 

 

166.5

 

Total revenue

 

 

29,172

 

 

 

25,688

 

 

 

3,484

 

 

 

13.6

 

 

 

113,671

 

 

 

76,190

 

 

 

37,481

 

 

 

49.2

 

Cost of revenues

 

 

13,201

 

 

 

8,959

 

 

 

4,242

 

 

 

47.3

 

 

 

46,899

 

 

 

26,353

 

 

 

20,546

 

 

 

78.0

 

Gross profit

 

 

15,971

 

 

 

16,729

 

 

 

(758

)

 

 

(4.5

)

 

 

66,772

 

 

 

49,837

 

 

 

16,935

 

 

 

34.0

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development, net

 

 

3,896

 

 

 

2,256

 

 

 

1,640

 

 

 

72.7

 

 

 

15,919

 

 

 

9,583

 

 

 

6,336

 

 

 

66.1

 

Clinical operations

 

 

3,479

 

 

 

1,797

 

 

 

1,682

 

 

 

93.6

 

 

 

9,365

 

 

 

4,332

 

 

 

5,033

 

 

 

116.2

 

Sales and marketing

 

 

25,516

 

 

 

17,685

 

 

 

7,831

 

 

 

44.3

 

 

 

100,641

 

 

 

47,705

 

 

 

52,936

 

 

 

111.0

 

General and administrative

 

 

11,658

 

 

 

6,001

 

 

 

5,657

 

 

 

94.3

 

 

 

34,770

 

 

 

10,199

 

 

 

24,571

 

 

 

240.9

 

Total operating expenses

 

 

44,549

 

 

 

27,739

 

 

 

16,810

 

 

 

60.6

 

 

 

160,695

 

 

 

71,819

 

 

 

88,876

 

 

 

123.7

 

Operating loss

 

 

28,578

 

 

 

11,010

 

 

 

17,568

 

 

 

159.6

 

 

 

93,923

 

 

 

21,982

 

 

 

71,941

 

 

 

327.3

 

Financial (income) expense, net

 

 

(7,528

)

 

 

110

 

 

 

(7,638

)

 

*

 

 

 

(31,228

)

 

 

364

 

 

 

(31,592

)

 

*

 

Loss before taxes on income

 

 

21,050

 

 

 

11,120

 

 

 

9,930

 

 

 

89.3

 

 

 

62,695

 

 

 

22,346

 

 

 

40,349

 

 

 

180.6

 

Taxes on income

 

 

18

 

 

 

12

 

 

 

6

 

 

 

50.0

 

 

 

47

 

 

 

24

 

 

 

23

 

 

 

95.8

 

Net loss

 

$

21,068

 

 

$

11,132

 

 

$

9,936

 

 

 

89.3

 

 

$

62,742

 

 

$

22,370

 

 

$

40,372

 

 

 

180.5

 

Net loss per share (1):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and Diluted

 

$

0.14

 

 

$

0.83

 

 

$

(0.69

)

 

 

(83.1

)

 

$

0.72

 

 

$

1.67

 

 

$

(0.95

)

 

 

(56.9

)

Weighted average number of common shares (1):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and Diluted

 

 

152,467

 

 

 

13,391

 

 

 

 

 

 

 

 

 

86,776

 

 

 

13,359

 

 

 

 

 

 

 

* = not meaningful

(1) Prior period results have been adjusted to reflect the exchange of Old Talkspace’s common stock for Talkspace’s common stock at an exchange ratio of approximately 1.134140 in June 2021 as a result of the Business Combination.

 

 


 

Talkspace, Inc.

Consolidated Balance Sheets

(Unaudited)

 

 

 

December 31,

 

(in thousands except share and per share data)

 

2021

 

 

2020

 

ASSETS

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

Cash and cash equivalents

 

$

198,256

 

 

$

13,248

 

Accounts receivable, net of allowance

 

 

5,512

 

 

 

5,914

 

Other current assets

 

 

9,562

 

 

 

1,515

 

Total current assets

 

 

213,330

 

 

 

20,677

 

Property and equipment, net

 

 

624

 

 

 

175

 

Deferred issuance cost

 

 

 

 

 

692

 

Intangible assets, net

 

 

3,436

 

 

 

5,195

 

Goodwill

 

 

6,134

 

 

 

6,134

 

Other long-term assets

 

 

82

 

 

 

 

Total assets

 

$

223,606

 

 

$

32,873

 

LIABILITIES, CONVERTIBLE PREFERRED STOCK AND
   STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

Accounts payable

 

$

7,429

 

 

$

7,901

 

Deferred revenues

 

 

7,186

 

 

 

5,172

 

Accrued expenses and other current liabilities

 

 

12,562

 

 

 

7,416

 

Total current liabilities

 

 

27,177

 

 

 

20,489

 

Warrant liabilities

 

 

4,070

 

 

 

 

Other long-term liabilities

 

 

86

 

 

 

 

Total liabilities

 

 

31,333

 

 

 

20,489

 

Commitments and contingencies

 

 

 

 

 

 

CONVERTIBLE PREFERRED STOCK:

 

 

 

 

 

 

Convertible preferred stock

 

 

 

 

 

111,282

 

STOCKHOLDERS’ EQUITY (DEFICIT):

 

 

 

 

 

 

Common stock (1)

 

 

15

 

 

 

1

 

Additional paid-in capital (1)

 

 

363,788

 

 

 

9,889

 

Accumulated deficit

 

 

(171,530

)

 

 

(108,788

)

Total stockholders’ equity (deficit)

 

 

192,273

 

 

 

(98,898

)

Total liabilities, convertible preferred stock and stockholders’ equity (deficit)

 

$

223,606

 

 

$

32,873

 

(1) Prior period results have been adjusted to reflect the exchange of Old Talkspace’s common stock for Talkspace’s common stock at an exchange ratio of approximately 1.134140 in June 2021 as a result of the Business Combination.

 

 


 

Talkspace, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

 

 

 

For the Years Ended
December 31,

 

(in thousands)

 

2021

 

 

2020

 

 

2019

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

Net loss

 

$

(62,742

)

 

$

(22,370

)

 

$

(29,086

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

1,973

 

 

 

379

 

 

 

59

 

Amortization of debt issuance costs

 

 

175

 

 

 

 

 

 

 

Warrant issuance cost and change in fair value

 

 

(31,784

)

 

 

 

 

 

 

Stock-based compensation

 

 

27,405

 

 

 

2,977

 

 

 

3,404

 

Increase in accounts receivable

 

 

402

 

 

 

(5,017

)

 

 

(840

)

Increase in other current assets

 

 

(8,053

)

 

 

(695

)

 

 

(216

)

Increase in accounts payable

 

 

503

 

 

 

2,561

 

 

 

3,277

 

Increase in deferred revenues

 

 

2,014

 

 

 

2,028

 

 

 

1,193

 

Increase in accrued expenses and other current liabilities

 

 

4,396

 

 

 

4,962

 

 

 

1,017

 

Net cash used in operating activities

 

 

(65,711

)

 

 

(15,175

)

 

 

(21,192

)

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Purchase of property and equipment

 

 

(663

)

 

 

(126

)

 

 

(138

)

Acquisition of business

 

 

 

 

 

(10,685

)

 

 

 

Purchase of an intangible asset

 

 

 

 

 

(939

)

 

 

 

Proceeds from restricted long-term bank deposit

 

 

 

 

 

447

 

 

 

 

Net cash used in investing activities

 

 

(663

)

 

 

(11,303

)

 

 

(138

)

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Proceeds from reverse capitalization, net of transaction costs

 

 

249,334

 

 

 

 

 

 

 

Proceeds from issuance of convertible preferred stock, net

 

 

 

 

 

 

 

 

51,204

 

Proceeds from borrowings

 

 

6,000

 

 

 

 

 

 

 

Repayment of borrowings

 

 

(6,000

)

 

 

 

 

 

 

Payment of debt issuance costs

 

 

(50

)

 

 

 

 

 

 

Proceeds from exercise of stock options

 

 

2,098

 

 

 

94

 

 

 

297

 

Net cash provided by financing activities

 

 

251,382

 

 

 

94

 

 

 

51,501

 

Net increase (decrease) in cash and cash equivalents

 

 

185,008

 

 

 

(26,384

)

 

 

30,171

 

Cash and cash equivalents at the beginning of the year

 

 

13,248

 

 

 

39,632

 

 

 

9,461

 

Cash and cash equivalents at the end of the year

 

$

198,256

 

 

$

13,248

 

 

$

39,632

 

 

 


 

 

 

Non-GAAP Financial Measures

In addition to our financial results determined in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP measure, is useful in evaluating our operating performance. We use adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. We believe that the use of adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. In addition, other companies, including companies in our industry, may calculate similarly titled non-GAAP measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measure as a tool for comparison. A reconciliation is provided below for this non-GAAP financial measure to net loss, the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review our GAAP financial measure and the reconciliation of our non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business.

Adjusted EBITDA

Adjusted EBITDA is a key performance measure that our management uses to assess our operating performance. Because adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes and in evaluating acquisition opportunities.

We calculate adjusted EBITDA as net loss adjusted to exclude (i) interest and other expenses (income), net, (ii) tax benefit and expense, (iii) depreciation and amortization (iv) stock-based compensation expense and (v) certain non-recurring expenses, where applicable.

Talkspace, Inc.

Reconciliation of Non-GAAP Results to GAAP Results

 

 

 

For the Three Months Ended
December 31,

 

 

For the Years Ended
December 31,

 

(in thousands)

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Net loss

 

 

$

(21,068

)

 

$

(11,132

)

 

$

(62,742

)

 

$

(22,370

)

Add:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

515

 

 

 

324

 

 

 

1,973

 

 

 

379

 

Financial (income) expense, net (1)

 

 

 

(7,528

)

 

 

110

 

 

 

(31,228

)

 

 

364

 

Taxes on income

 

 

 

18

 

 

 

12

 

 

 

47

 

 

 

24

 

Stock-based compensation

 

 

 

6,821

 

 

 

1,908

 

 

 

27,405

 

 

 

2,977

 

Non-recurring expenses (2)

 

 

 

3,677

 

 

 

177

 

 

 

3,677

 

 

 

177

 

Adjusted EBITDA

 

 

$

(17,565

)

 

$

(8,601

)

 

$

(60,868

)

 

$

(18,449

)

(1) For the three months ended December 31, 2021, financial income, net primarily consisted of $7.9 million in gains resulting from the revaluation of warrant liabilities. For the twelve months ended December 31, 2021, financial income, net primarily consisted of $36.0 million in gains resulting from the revaluation of warrant liabilities, partially offset by $4.2 million in warrant issuance costs in connection with the close of the Business Combination.

(2) For the year ended December 31, 2021, non-recurring expenses primarily consisted of severance costs related to the separation of Oren Frank and Roni Frank, co-founders and former executives of the Company, in November 2021. For the year ended December 31, 2020, nonrecurring expenses consisted of legal expenses related to the acquisition of Lasting in November 2020.